
Eptifab (Eptifibatide) Injection
Generic API Name: Eptifibatide. Generic Branded Name: Eptifab. Generic brand for Eptifab (Eptifibatide) Injection is available in India. Eptifab, is a blood thinner used to prevent blood clots and reduce the risk of cardiovascular events like heart attack, particularly during or after procedures like angioplasty. It contains the active substance Eptifibatide. Eptifab is a prescription medication that must be administered in your doctor’s office. Generic Eptifibatide (Brand name Eptifab) Available in India Brand Name Eptifab Generic Name Eptifibatide Strength Manufacturer Abbott India What is the cost of Eptifibatide in India? Place your order today to receive authentic medications, enjoy maximum discounts on medicines, prescription drugs, and health products. Aark Pharmaceuticals, network
About Eptifab (Eptifibatide) Injection
Description Generic Version of Eptifibatide Available in India? Eptifibatide is the generic name of the medication and is its international nonproprietary name. Eptifibatide is marketed under the brand name Eptifab among others. Eptifibatide is used to reduce the risk of acute cardiac ischemic events (death and/or myocardial infarction) in patients with unstable angina or non-ST-segment-elevation (e.g., non-Q-wave) myocardial infarction both in patients who are to receive non surgery (conservative) medical treatment and those undergoing percutaneous coronary intervention (PCI). Will this product be accessible across all regions of India? The product – Eptifab (Eptifibatide) Injection will be available across India on request. Eptifibatide is available in all the major cities in India – Delhi, Chandigarh, Jodhpur, Patna, Kolkata, Lucknow, Hyderabad, Chennai, Ahmedabad, Bangalore, and Pune. To get or place an order from Aark Pharmaceuticals, a pharma distributor in India, please call us at +91 999915 6233 , You can also make an inquiry by emailing us at sales@aarkpharma.co.in , sales@aarkpharma.com , WhatsApp: +91 9999156233 . NEWS / UPDATES Written By Mr. Sandeep Tomar (D. pharma) Last updated 10 March 2025 | 10:10 AM (IST)




